“…Camptothecin (CPT), which originally isolated from the wood and bark of Camptotheca acuminatain, is a topoisomerase I poison that exhibits potent anticancer efficacy against a variety of tumors. − However, CPT is faced with limitations such as low aqueous solubility and high toxicity issues, restricting its clinical development in cancer treatment. − A number of approaches have been proposed to overcome these problems, ,− such as using macrocycles that can act as molecular container compounds. − Among these, cucurbit[ n ]urils (CB[ n ], n = 5, 6, 7, 8, 10), which are pumpkinlike molecular containers composed of glycoluril monomers linked by methylene bridges, have been developing rapidly. − Recently, Cheng et al reported the synthesis of a new cucurbituril homologue, named twisted Q[14], tQ[14], which has 14 units of −glycoluril-(CH2)2– moiety with a twisted structure . CB[ n ]s have a rigid structure containing a hydrophobic cavity and hydrophilic carbonyl-fringed portals. − The utility of these macrocycles has been significantly revealed in the wide range of exciting applications including catalysis, molecular recognition, molecular machines, biomedicine, rotaxanes, pseudorotaxanes, and drug delivery vehicle. ,,,, For example, Dong et al used CB[7] and CB[8] to improve the solubility properties of CPT and showed that the solubility of CPT increased up to 70 and 8 times for the CPT@CB[7] and CPT@CB[8] complexes, respectively (pH = 2).…”